Monday July 16, 2018
Home India Divided into ...

Divided into Two: ‘Gora’ and ‘Kala’, Bene Israel is a Jewish community from India

0
//
641
An Bene Israel Family Image source: indianquarterly.com
Republish
Reprint
  • Bene Israels are also known as Indian Jews
  • There are total 80,000 Indian Jews in Israel
  • Most Bene Jews are of view that they left India because their community growth was continuously declining in India

Bene Israel meaning ‘Sons of Israel’ are said to have migrated from India over the last few decades. It will surprise many that they are also known as Indian Jews community. This  is one of the 4 sub-communities of Jews and now in Israel, there are about 80,000 Indian Jews.

Jewish lady. Image Souce: Wikimedia Commons
Jewish lady. Image Source: Wikimedia Commons

The population includes- Cochin jews, Baghdadi Jews (Jews belong from Kolkata) and those belonging to ‘Manashe’ tribe from Manipur. However, the Bene Israel continues to believe that their ancestors belong to the Konkan area in India.

After India achieved freedom in 1947 and a year later, Israel was formed in 1948. All Jews migrated to Israel as they felt their conditions were precarious in India. Bene Israel believes that around 1000 AD Jewish merchant David Rahabi came into India led the foundation of Bene Israel, said thehindu.com report.

Follow NewsGram on Twitter: @newsgram1

Bene Israel divides themselves into two groups- ‘Gora’ means white and ‘Kala’ means black. It says that whose both mother and father are Jews falls in Gora community while the Kala constitutes people whose fathers are Jewish and mother from any other community. There is a discrimination in these two communities. Gora defines them as superiors and does not mingle with Kala and member from Gora community cannot marry anyone from Kala community.

The Bene Jews had a unique custom known as ‘Malida’. In Malida, Bene Israel sits with a plate full of rice, spices, fruits and flowers. During this, they praise Lord by singing songs and narrate two stories about Prophet Elijah.

Malida custom of Bene Jews. Image Souce: forward.com
Malida custom of Bene Jews. Image Source: forward.com

According to a report in The Hindu, Bene Israel does not consider themselves as Jews until the 20th century. They were known as ‘Yehudi’ or ‘Bene Israel’ until the 20th century, but now they refer themselves as Jews. Today, many people in India also refer Jews as Bene Israel or Israel.

Follow NewsGram on Facebook: NewsGram.com

Most Bene Jews share the view that they left India because their community growth was continuously declining in India. Unlike, UK and USA, they do not enjoy the same position as other Jews in Israel. While most of the Jews migrated to Israel, a small population migrated to English-speaking countries like Australia, UK and USA.

Now there are only 5,000 Bene Israels are left in India, out of which, more than 90% lives in Thana, a suburb of Mumbai.

-This article is compiled by a staff-writer at NewsGram.

ALSO READ:

Click here for reuse options!
Copyright 2016 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)